Structural Formula Dextrose (Dextrose 01)
Dextrose Injection, Solution
Product Images NDC 0409-7100
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Dextrose (NDC 0409-7100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Dextrose 02)
Figure 2 (Dextrose 03)
Figure 3 (Dextrose 04)
Figure 4 (Dextrose 05)
Figure 5 (Dextrose 06)
Figure 6 (Dextrose 07)
Figure 7 (Dextrose 08)
Hospira Logo (Dextrose 09)
Bag Ndc 0409-7100-68 (Dextrose 10)
This is a description of a medical product called ADD-Vantage™ Unit. The text provides directions on how to use the drug, which includes pulling the inner plug/stopper and mixing the drug before use. The product is intended for intravenous use and contains 5% dextrose. The package contains a single-dose container and is sterile and non-pyrogenic. The text warns against the use of dextrose solutions without salts in blood transfusions due to possible rouleau formation. It notes that the product should only be used with ADD-Vantage™ system components and provides the NDC number (0409-7100-68). The text also provides information on the product's pH, osmolality, and dosage information. Finally, there are instructions for ensuring product integrity, including checking for clear solutions and undamaged containers.*
Bag Ndc 0409-7100-69 (Dextrose 11)
Principal Display Panel (250 mL Bag Label)
The text is a warning label on a container of 5% Dextrose Injection for intravenous use with instructions to mix the drug before use and not to use with blood transfusions. It also states that the drug should only be used with ADD-Vantage™ System components and must not be used in series connections. The container is sterile and nonpyrogenic. It is distributed by Hospira, Inc. in Lake Forest, IL, USA. The text contains a lot number, a National Drug Code (NDC) number, and a warning that the solution contains DEHP.*
Principal Display Panel (Pouch Label)
This is a description for the One/ADD-Vantage™ unit intended for use with ADD-Vantage™ system components. The overwrap functions as a moisture barrier, and the unit should be used within 30 days of opening the overwrap, provided the use date is before the expiration date. The recommended storage temperature is between 20-25°C (68-77°F), with protection against freezing. After removing the overwrap, the container should be checked for leaks. If any leaks are found, the unit should be discarded as the sterility could be compromised. This product is distributed by Hospira, Inc. from Lake Forest, IL 60045.*
Dextrose 14
This text provides instructions for opening and using Five/ADD-Vantage™ Units, which are intended for use with ADD-Vantage™ system components. The overwrap serves as a moisture barrier and units should be used within 30 days of opening, as long as the expiration date is not exceeded. It is important to check for leaks after removing the overwrap; any leaks found may impair sterility and require unit disposal. Proper storage temperature is between 20°C to 25°C. The text also indicates that this product is prescription-only and distributed by Hospira, Inc. in Lake Forest, IL, USA.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
